Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H28F3N3O4 |
Molecular Weight | 503.5134 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](OC1=CC(C)=C(N2C=C(C=N2)C(F)(F)F)C(C)=C1)C3=CC=C(C=C3)C(=O)NCCC(O)=O
InChI
InChIKey=IBDYYOQKQCCSDP-QFIPXVFZSA-N
InChI=1S/C26H28F3N3O4/c1-4-5-22(18-6-8-19(9-7-18)25(35)30-11-10-23(33)34)36-21-12-16(2)24(17(3)13-21)32-15-20(14-31-32)26(27,28)29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1985 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23562063 |
14.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus. | 2016 Aug |
|
A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus. | 2017 Apr |
|
Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy. | 2018 Nov |
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1393124-08-7
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY | |||
|
60151939
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY | |||
|
DB15065
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544946
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY | |||
|
CGY4I8F278
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY | |||
|
100000182683
Created by
admin on Sat Dec 16 01:34:58 GMT 2023 , Edited by admin on Sat Dec 16 01:34:58 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD